Report Detail
Global Imipenem Market Insights, Forecast to 2025
- RnM3525729 |
- 14 June, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Imipenem is a broad spectrum carbapenem antibiotic which is used for severe bacterial infections.
The global Imipenem market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Imipenem market based on company, product type, end user and key regions.
This report studies the global market size of Imipenem in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Imipenem in these regions.
This research report categorizes the global Imipenem market by top players/brands, region, type and end user. This report also studies the global Imipenem market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
HISUN Pharmaceutical
Haibin Pharmaceutical
United Lab
Market size by Product
Sterile Type
Non-sterile Type
Market size by End User
Injection
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Imipenem market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Imipenem market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Imipenem companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Imipenem submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Imipenem are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Imipenem market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Imipenem Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Imipenem Market Size Growth Rate by Product
- 1.4.2 Sterile Type
- 1.4.3 Non-sterile Type
- 1.5 Market by End User
- 1.5.1 Global Imipenem Market Size Growth Rate by End User
- 1.5.2 Injection
- 1.5.3 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Imipenem Market Size
- 2.1.1 Global Imipenem Revenue 2014-2025
- 2.1.2 Global Imipenem Sales 2014-2025
- 2.2 Imipenem Growth Rate by Regions
- 2.2.1 Global Imipenem Sales by Regions
- 2.2.2 Global Imipenem Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Imipenem Sales by Manufacturers
- 3.1.1 Imipenem Sales by Manufacturers
- 3.1.2 Imipenem Sales Market Share by Manufacturers
- 3.1.3 Global Imipenem Market Concentration Ratio (CR5 and HHI)
- 3.2 Imipenem Revenue by Manufacturers
- 3.2.1 Imipenem Revenue by Manufacturers (2014-2019)
- 3.2.2 Imipenem Revenue Share by Manufacturers (2014-2019)
- 3.3 Imipenem Price by Manufacturers
- 3.4 Imipenem Manufacturing Base Distribution, Product Types
- 3.4.1 Imipenem Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Imipenem Product Type
- 3.4.3 Date of International Manufacturers Enter into Imipenem Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Imipenem Sales by Product
- 4.2 Global Imipenem Revenue by Product
- 4.3 Imipenem Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Imipenem Breakdown Data by End User
6 North America
- 6.1 North America Imipenem by Countries
- 6.1.1 North America Imipenem Sales by Countries
- 6.1.2 North America Imipenem Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Imipenem by Product
- 6.3 North America Imipenem by End User
7 Europe
- 7.1 Europe Imipenem by Countries
- 7.1.1 Europe Imipenem Sales by Countries
- 7.1.2 Europe Imipenem Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Imipenem by Product
- 7.3 Europe Imipenem by End User
8 Asia Pacific
- 8.1 Asia Pacific Imipenem by Countries
- 8.1.1 Asia Pacific Imipenem Sales by Countries
- 8.1.2 Asia Pacific Imipenem Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Imipenem by Product
- 8.3 Asia Pacific Imipenem by End User
9 Central & South America
- 9.1 Central & South America Imipenem by Countries
- 9.1.1 Central & South America Imipenem Sales by Countries
- 9.1.2 Central & South America Imipenem Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Imipenem by Product
- 9.3 Central & South America Imipenem by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Imipenem by Countries
- 10.1.1 Middle East and Africa Imipenem Sales by Countries
- 10.1.2 Middle East and Africa Imipenem Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Imipenem by Product
- 10.3 Middle East and Africa Imipenem by End User
11 Company Profiles
- 11.1 Savior Lifetec
- 11.1.1 Savior Lifetec Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Savior Lifetec Imipenem Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Savior Lifetec Imipenem Products Offered
- 11.1.5 Savior Lifetec Recent Development
- 11.2 Sun Pharmaceutical Industries
- 11.2.1 Sun Pharmaceutical Industries Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sun Pharmaceutical Industries Imipenem Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sun Pharmaceutical Industries Imipenem Products Offered
- 11.2.5 Sun Pharmaceutical Industries Recent Development
- 11.3 Kopran
- 11.3.1 Kopran Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Kopran Imipenem Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Kopran Imipenem Products Offered
- 11.3.5 Kopran Recent Development
- 11.4 HISUN Pharmaceutical
- 11.4.1 HISUN Pharmaceutical Company Details
- 11.4.2 Company Business Overview
- 11.4.3 HISUN Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 HISUN Pharmaceutical Imipenem Products Offered
- 11.4.5 HISUN Pharmaceutical Recent Development
- 11.5 Haibin Pharmaceutical
- 11.5.1 Haibin Pharmaceutical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Haibin Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Haibin Pharmaceutical Imipenem Products Offered
- 11.5.5 Haibin Pharmaceutical Recent Development
- 11.6 United Lab
- 11.6.1 United Lab Company Details
- 11.6.2 Company Business Overview
- 11.6.3 United Lab Imipenem Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 United Lab Imipenem Products Offered
- 11.6.5 United Lab Recent Development
12 Future Forecast
- 12.1 Imipenem Market Forecast by Regions
- 12.1.1 Global Imipenem Sales Forecast by Regions 2019-2025
- 12.1.2 Global Imipenem Revenue Forecast by Regions 2019-2025
- 12.2 Imipenem Market Forecast by Product
- 12.2.1 Global Imipenem Sales Forecast by Product 2019-2025
- 12.2.2 Global Imipenem Revenue Forecast by Product 2019-2025
- 12.3 Imipenem Market Forecast by End User
- 12.4 North America Imipenem Forecast
- 12.5 Europe Imipenem Forecast
- 12.6 Asia Pacific Imipenem Forecast
- 12.7 Central & South America Imipenem Forecast
- 12.8 Middle East and Africa Imipenem Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Imipenem Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Imipenem. Industry analysis & Market Report on Imipenem is a syndicated market report, published as Global Imipenem Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Imipenem market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
